Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome
出版年份 2014 全文链接
标题
Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome
作者
关键词
-
出版物
Annals of the New York Academy of Sciences
Volume 1329, Issue 1, Pages 45-66
出版商
Wiley
发表日期
2014-08-22
DOI
10.1111/nyas.12508
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
- (2014) P. J. Garcia-Ruiz et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Continuous Drug Delivery in Parkinson’s Disease
- (2013) Marina Senek et al. CNS DRUGS
- Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations
- (2013) Jan-Peer Elshoff et al. CURRENT MEDICAL RESEARCH AND OPINION
- Restless legs syndrome in end-stage renal disease: a multicenter study in Taiwan
- (2013) C.-H. Lin et al. EUROPEAN JOURNAL OF NEUROLOGY
- Effects of rotigotine transdermal system on non-motor symptoms in Parkinson’s disease: an overview
- (2013) Theresa A Zesiewicz et al. Expert Review of Neurotherapeutics
- The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson’s disease
- (2013) Nir Giladi et al. JOURNAL OF NEURAL TRANSMISSION
- Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
- (2013) K. Ray Chaudhuri et al. JOURNAL OF NEURAL TRANSMISSION
- The relationship among restless legs syndrome (Willis–Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease
- (2013) Luigi Ferini-Strambi et al. JOURNAL OF NEUROLOGY
- Nonmotor Symptoms in Nursing Home Residents with Parkinson's Disease: Prevalence and Effect on Quality of Life
- (2013) Nico J. Weerkamp et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease
- (2013) Diego Santos-García et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review
- (2013) Christoforos D. Giannaki et al. KIDNEY INTERNATIONAL
- Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
- (2013) Gordon W. Duncan et al. MOVEMENT DISORDERS
- The current and projected economic burden of Parkinson's disease in the United States
- (2013) Stacey L. Kowal et al. MOVEMENT DISORDERS
- The Development of the Rotigotine Transdermal Patch
- (2013) Cheryl Waters NEUROLOGIC CLINICS
- Patients Suffering from Restless Legs Syndrome Have Low Internal Locus of Control and Poor Psychological Functioning Compared to Healthy Controls
- (2013) Serge Brand et al. NEUROPSYCHOBIOLOGY
- The impact of non-motor symptoms on the Health-Related Quality of Life of Parkinson's disease patients from Southwest China
- (2013) Wei Song et al. PARKINSONISM & RELATED DISORDERS
- Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany
- (2013) Karin Stiasny-Kolster et al. SLEEP MEDICINE
- Application of the concept of continuous dopaminergic stimulation for the management of Parkinson’s disease
- (2013) Qing Lv et al. Neuroscience Bulletin
- Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies
- (2012) Jan-Peer Elshoff et al. CLINICAL THERAPEUTICS
- Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: apost-hocanalysis of patients taking 1 – 3 mg/24 h for up to 5 years
- (2012) Elisabeth Dohin et al. EXPERT OPINION ON PHARMACOTHERAPY
- Non-motor symptoms of Parkinson’s disease: the patient’s perspective
- (2012) Kieran C. Breen et al. JOURNAL OF NEURAL TRANSMISSION
- Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
- (2012) Peter A. LeWitt et al. JOURNAL OF NEURAL TRANSMISSION
- The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life
- (2012) Angelo Antonini et al. JOURNAL OF NEUROLOGY
- Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study
- (2012) Lawrence W. Elmer et al. PARKINSONISM & RELATED DISORDERS
- Treatment of patients with early and advanced Parkinson's disease with rotigotine transdermal system: Age-relationship to safety and tolerability
- (2012) Wolfgang Oertel et al. PARKINSONISM & RELATED DISORDERS
- Assessing health-related quality of life in patients with restless legs syndrome in Korea: Comparison with other chronic medical diseases
- (2012) Yong Won Cho et al. SLEEP MEDICINE
- Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease)
- (2012) D. Tzonova et al. SLEEP MEDICINE
- Augmentation in the treatment of restless legs syndrome with transdermal rotigotine
- (2012) Heike Beneš et al. SLEEP MEDICINE
- Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
- (2011) Han-Joon Kim et al. BMC Neurology
- Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome
- (2011) Valerie Voon et al. BMC Neurology
- Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function
- (2011) Willi Cawello et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence
- (2011) Karin Wirdefeldt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Effect of rotigotine on sleep and quality of life in Parkinson's disease patients:post hocanalysis of RECOVER patients who were symptomatic at baseline
- (2011) Liesbet Ghys et al. EXPERT OPINION ON PHARMACOTHERAPY
- Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study
- (2011) Hanna Scholz et al. Health and Quality of Life Outcomes
- Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression
- (2011) P. Jenner et al. JOURNAL OF NEURAL TRANSMISSION
- Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
- (2011) Wolfgang Oertel et al. LANCET NEUROLOGY
- The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease
- (2011) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Parkinson's disease sleep scale-validation of the revised version PDSS-2
- (2011) Claudia Trenkwalder et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease
- (2011) Klaus Seppi et al. MOVEMENT DISORDERS
- Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies
- (2011) A. Hassan et al. PARKINSONISM & RELATED DISORDERS
- Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome
- (2011) S.R. Schreglmann et al. PARKINSONISM & RELATED DISORDERS
- Prevalence of restless legs syndrome in North American and Western European populations: A systematic review
- (2011) Kim E. Innes et al. SLEEP MEDICINE
- Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: A systematic review
- (2011) Kim E. Innes et al. SLEEP MEDICINE REVIEWS
- Epidemiology of restless legs syndrome: A synthesis of the literature
- (2011) Maurice M. Ohayon et al. SLEEP MEDICINE REVIEWS
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Therapeutic Role of 5-HT1A Receptors in The Treatment of Schizophrenia and Parkinson's Disease
- (2010) Yukihiro Ohno CNS Neuroscience & Therapeutics
- Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States
- (2010) Wayne A. Hening et al. MOVEMENT DISORDERS
- Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)
- (2010) Claudia Trenkwalder et al. MOVEMENT DISORDERS
- Restless legs syndrome: pathophysiology, clinical presentation and management
- (2010) Claudia Trenkwalder et al. Nature Reviews Neurology
- Gastrointestinal dysfunction in Parkinson’s disease
- (2010) Ronald F. Pfeiffer PARKINSONISM & RELATED DISORDERS
- Health Economic Burden of Patients with Restless Legs Syndrome in a German Ambulatory Setting
- (2010) Richard Dodel et al. PHARMACOECONOMICS
- Health-related quality of life and restless legs syndrome among women in Sweden
- (2010) Jan Wesström et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Restless legs syndrome in end-stage renal disease: Clinical characteristics and associated comorbidities
- (2010) Sonia Maria Holanda Almeida Araujo et al. SLEEP MEDICINE
- Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: A randomized, placebo-controlled polysomnographic study
- (2010) Wolfgang H. Oertel et al. SLEEP MEDICINE
- Dopaminergic augmentation of restless legs syndrome
- (2010) Diego García-Borreguero et al. SLEEP MEDICINE REVIEWS
- Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive
- (2009) Marina Braun et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Neurotransmission in Parkinson’s disease: beyond dopamine
- (2009) P. Barone EUROPEAN JOURNAL OF NEUROLOGY
- Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction
- (2009) K.A. Stockwell et al. EXPERIMENTAL NEUROLOGY
- Rotigotine transdermal delivery for the treatment of Parkinson's disease
- (2009) Olivier Rascol et al. EXPERT OPINION ON PHARMACOTHERAPY
- Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa
- (2009) Marina Braun et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease
- (2009) Paolo Barone et al. MOVEMENT DISORDERS
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease
- (2009) Peter Jenner PARKINSONISM & RELATED DISORDERS
- Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine
- (2008) Marina Braun et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Impulse Control Disorders Arising in 3 Patients Treated With Rotigotine
- (2008) Thomas S. Wingo et al. CLINICAL NEUROPHARMACOLOGY
- Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine
- (2008) M Malik et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rotigotine transdermal system for the treatment of Parkinson's disease
- (2008) David Q. Pham et al. CLINICAL THERAPEUTICS
- Crystallisation within transdermal rotigotine patch: is there cause for concern?
- (2008) K Ray Chaudhuri Expert Opinion on Drug Delivery
- Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements
- (2008) Werner J. Schmidt et al. JOURNAL OF NEURAL TRANSMISSION
- Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial
- (2008) Claudia Trenkwalder et al. LANCET NEUROLOGY
- Non-dopaminergic treatments in development for Parkinson's disease
- (2008) Susan H Fox et al. LANCET NEUROLOGY
- The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease
- (2008) Dieter Scheller et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe
- (2007) Wolfgang H. Oertel et al. SLEEP MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now